Innovation Theaters

Saturday, June 11, 2022

7:30 am - 8:30 am EST

A Clinical Overview of a Prescription Treatment for Patients With Moderately to Severely Active Ulcerative Colitis

Faculty:
Adam Stein, MD

Sponsored By Pfizer

___________________________________________________________________________

11:40 am - 12:40 pm EST

UC Powerful Evidence

Faculty:
Amar Naik, MD

Sponsored By AbbVie

___________________________________________________________________________

3:10 pm - 4:10 pm EST

Advancing Care for Crohn's Disease Proactively managing Crohn's disease in today's world

Sponsored By AbbVie

___________________________________________________________________________

6:00 pm - 7:00 pm EST

Another Day is Dawning in UC: Zeposia (Ozanimod): A Once -Daily Oral Therapy for the Treatment of Moderately to Severely Active Ulcerative Colitis (UC) in Adults

Faculty:
Caterina Oneto, MD

Sponsored By Bristol Myers Squibb